Medtronic gets FDA nod for blood sugar monitoring device

martedì 29 gennaio 2008 14:24

Jan 29 (Reuters) - Medtronic Inc (MDT.N: Quotazione) said U.S. health regulators approved its blood sugar monitoring device, the CGMS iPro Recorder.

The U.S. medical device maker said patients wear the device for three days, after which physicians can review the data and use the results to uncover glucose patterns. (Reporting by Avishek Mishra in Bangalore; Editing by Himani Sarkar)